相关实验视频
Updated: Sep 15, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
对调节血小板聚合的天然化合物的审查:分子机制和研究进展
Yi Hou1, Hong Li2, Luochen Zhu3
1Pharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.
自然化合物可以通过多种途径调节血小板聚合,包括ADP,cAMP/cGMP和酸代谢. 本综述详细介绍了这些机制的潜在治疗应用.
科学领域:
- 生物化学 生化学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血小板对于静血至关重要,它们的聚合受到信号通路的严格调节.
- 不正常的血小板聚合与血栓形成和出血性疾病有关,通常是由于受体功能障碍或信号错误.
- 自然化合物在调节不同细胞水平的血小板聚合方面表现出潜力.
研究的目的:
- 综合审查天然化合物的抗血小板聚合机制.
- 详细阐述影响血小板聚合的关键信号通路.
- 为血小板研究和临床研究中的天然化合物应用提供参考.
主要方法:
- 文献综述侧重于自然化合物和血小板聚合途径.
- 分析涉及腺二酸盐 (ADP),cAMP/cGMP水平和酸代谢 (ARA) 的机制.
- 检查血栓和原介导的血小板激活通路.
主要成果:
- 天然化合物,包括糖化物,胺,和酸,通过各种机制影响血小板聚合.
- 讨论的关键途径包括ADP信号传递,cAMP/cGMP调节,ARA代谢和血栓/原路径.
- 自然化合物的结构特征是它们抗血小板作用的关键.
结论:
- 自然化合物为了解和操纵血小板聚合提供了一个有希望的途径.
- 对这些化合物的进一步研究可以为新型抗血小板疗法的开发提供信息.
- 本综述为研究人员和临床医生在血小板生物学领域提供了宝贵的资源.
更多相关视频
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins